Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ZBIO — Zenas BioPharma, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in ZBIO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,661,847
+$1,165,199 QoQ
Shares Held
85,005
+521.5% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ZBIO Over Time

Shares Held

Position Value (USD)

Derivatives in ZBIO

reported options exposure · as of Mar 31, 2026
CallValue
$2,402,695
CallShares
122,900
PutValue
$1,135,855
PutShares
58,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. ZBIO ranks #125 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZBIO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,135,855 58,100
2026-03-31 $2,402,695 122,900
2026-03-31 $1,661,847 85,005
2025-12-31 $496,648 13,678
2025-12-31 $257,801 7,100
2025-12-31 $1,336,208 36,800
2025-09-30 $224,220 10,100
2025-06-30 $189,352 19,541
2025-03-31 $147,232 18,637